Disease Information & Support

www.lls.org/diseaseinformation

The Word:

donate

Generic name Fludarabine
Pronunciation floo-DARE-a-been
Brand name(s), other common name(s) Fludara®
Drug type  Antimetabolite
How the drug is given Intravenously (IV)

Fludarabine is FDA approved to treat people who have chronic lymphocytic leukemia (CLL) who have not responded to at least one standard alkylting-agent-containing regimen or whose disease has progressed during treatment with such a regimen. This medicine may rarely cause a temporary loss of hair. After treatment with fludarabine has ended, normal hair growth should return.

Side effects needing medical attention: Cough; sore throat; fever; chills; sores or white patches on mouth or lips; unusual bleeding or bruising; fatigue; chest pain; shortness of breath; pain or burning on urination; lower back or side pain; black, tarry stools; blood in urine; pinhead-sized red spots on skin; agitation or confusion; blurred vision; loss of hearing; numbness or tingling in fingers, toes or face; swelling of feet or lower legs; unusual tiredness or weakness; nausea and vomiting; diarrhea; hair loss; aching muscles; general feeling of discomfort or illness; headache; loss of appetite.

Side effects needing medical attention after stopping this medication: Cough or hoarseness; fever or chills; loss of vision; lower back or side pain; painful or difficult urination; shortness of breath or wheezing; weakness; black, tarry stools; blood in urine or stool; back, lower back or side pain; pinhead-sized red spots on skin or rash; itching; sweating; swelling of face or tongue; tightness in throat; loss of appetite; hair loss; nausea and vomiting; diarrhea; unusual tiredness.

 

For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Monday, October 15, 2012